Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 6601 to 6650 of 8236 results

  1. BRAHMS copeptin assay to rule out myocardial infarction in patients with acute chest pain (MTG4)

    In November 2016, NICE reviewed this guidance and recommended that it should be withdrawn. The guidance was published in June 2011 and recommended that further research was carried out on the technology. There was insufficient evidence on its use in clinical practice to recommend adoption. On reviewing the guidance in 2016, NICE determined that: The comparator in the original guidance, standard serial troponin testing, was changed in 2014 to high sensitivity troponin testing which expert advice indicated is now widespread in the NHS The clinical pathway in the original evaluation has significantly changed and the original scope is no longer valid. These changes mean that the current guidance is no longer valid and NICE would not be able to update it. The guidance has therefore been withdrawn. For a copy of the review decision please contact nice@nice.org.uk.

    Medical technologies guidance
    Published
    22 June 2011

  2. The Prosigna gene expression profiling assay for assessing long‑term risk of breast cancer recurrence (MIB27)

    This advice has been updated and replaced by NICE diagnostics guidance 34.

    Medtech innovation briefing
    Published
    25 March 2015

  3. Episcissors-60 for guided mediolateral episiotomy (MIB33)

    This advice has been updated and replaced by NICE medical technologies guidance 47.

    Medtech innovation briefing
    Published
    21 July 2015

  4. AliveCor Heart Monitor and AliveECG app (Kardia Mobile) for detecting atrial fibrillation (MIB35)

    This advice has been updated and replaced by NICE medtech innovation briefing 232.

    Medtech innovation briefing
    Published
    5 August 2015

  5. Self-harm in over 8s: short-term management and prevention of recurrence (CG16)

    This guidance has been updated and replaced by NICE guideline NG225.

    Clinical guideline
    Published
    28 July 2004

  6. Fever in under 5s: assessment and initial management (CG160)

    This guidance has been updated and replaced by NICE guideline NG143.

    Clinical guideline
    Published
    22 May 2013

  7. Stroke rehabilitation in adults (CG162)

    This guidance has been updated and replaced by NICE guideline NG236.

    Clinical guideline
    Published
    12 June 2013

  8. Familial breast cancer (CG14)

    This guidance has been updated and replaced by NICE guideline CG41.

    Clinical guideline
    Published
    23 May 2004

  9. Venous thromboembolic diseases: diagnosis, management and thrombophilia testing (CG144)

    This guidance has been updated and replaced by NICE guideline NG158.

    Clinical guideline
    Published
    27 June 2012

  10. Clostridium difficile infection: fidaxomicin (ESNM1)

    This advice has been updated and replaced by NICE guideline NG199.

    Evidence summary
    Published
    13 July 2012

  11. Type 2 diabetes: lixisenatide (ESNM10)

    This evidence summary has been updated and replaced by NICE advice ESNM26.

    Evidence summary
    Published
    18 January 2013

  12. Acute diarrhoea in adults: racecadotril (ESNM11)

    This evidence summary has been withdrawn because the product is no longer available in the UK.

    Evidence summary
    Published
    12 March 2013

  13. Acute diarrhoea in children: racecadotril as an adjunct to oral rehydration (ESNM12)

    This evidence summary has been withdrawn because the product is no longer available in the UK.

    Evidence summary
    Published
    12 March 2013

  14. Non-cystic fibrosis bronchiectasis: inhaled tobramycin (ES12)

    This evidence summary has been updated and replaced by NICE guideline NG117.

    Evidence summary
    Published
    4 April 2017

  15. Early breast cancer (preventing recurrence and improving survival): adjuvant bisphosphonates (ES15)

    This evidence summary has been updated and replaced by NICE guideline NG101.

    Evidence summary
    Published
    25 July 2017

  16. Chronic obstructive pulmonary disease: beclometasone, formoterol and glycopyrronium (Trimbow) (ES17)

    This evidence summary has been updated and replaced by NICE guideline 115.

    Evidence summary
    Published
    3 May 2018

  17. Oestrogen deficiency symptoms in postmenopausal women: conjugated oestrogens and bazedoxifene acetate (ES3)

    This evidence summary has been withdrawn because the product is no longer available in the UK.

    Evidence summary
    Published
    22 December 2016

  18. Antimicrobial prescribing: cefiderocol (ES31)

    This evidence summary has been updated and replaced by NICE antimicrobial health technology evaluation guidance on cefiderocol for treating severe drug-resistant gram-negative bacterial infections.

    Evidence summary
    Published
    2 December 2020

  19. Actinic keratosis: ingenol mebutate gel (ESNM14)

    This evidence summary has been withdrawn as the licence of ingenol mebutate gel has been suspended.

    Evidence summary
    Published
    19 March 2013

  20. Schizophrenia: lurasidone (ESNM15)

    This evidence summary has been replaced by ESNM48

    Evidence summary
    Published
    9 April 2013

  21. Irritable bowel syndrome with constipation in adults: linaclotide (ESNM16)

    This evidence summary has been updated and replaced by NICE guideline CG61.

    Evidence summary
    Published
    9 April 2013

  22. Partial-onset seizures in epilepsy: zonisamide as monotherapy (ESNM17)

    This evidence summary has been updated and replaced by NICE guideline NG217.

    Evidence summary
    Published
    16 April 2013

  23. Lower urinary tract symptoms secondary to benign prostatic hyperplasia: tadalafil (ESNM18)

    This evidence summary has been updated and replaced by NICE guideline CG97.

    Evidence summary
    Published
    23 May 2013

  24. Attention deficit hyperactivity disorder in children and young people: lisdexamfetamine dimesylate (ESNM19)

    This evidence summary has been updated and replaced by NICE guideline NG87.

    Evidence summary
    Published
    7 May 2013

  25. Idiopathic overactive bladder syndrome: botulinum toxin A (ESNM2)

    This evidence summary has been replaced by NICE guideline CG171.

    Evidence summary
    Published
    1 September 2012

  26. Type 2 diabetes: alogliptin (ESNM20)

    This evidence summary has been updated and replaced by NICE guideline NG28.

    Evidence summary
    Published
    21 May 2013

  27. Chronic obstructive pulmonary disease: fluticasone furoate plus vilanterol (ESNM21)

    This evidence summary has been updated and replaced by NICE guideline 115.

    Evidence summary
    Published
    18 June 2013

  28. Asthma: beclometasone/formoterol (Fostair) for maintenance and reliever treatment (ESNM22)

    This evidence summary has been updated and replaced by NICE guideline NG80.

    Evidence summary
    Published
    25 June 2013

  29. Gouty arthritis: canakinumab (ESNM23)

    This advice has been updated and replaced by NICE guideline NG219.

    Evidence summary
    Published
    23 July 2013

  30. Type 1 diabetes: insulin degludec (ESNM24)

    This evidence summary has been updated and replaced by NICE guideline NG17.

    Evidence summary
    Published
    10 September 2013

  31. Type 2 diabetes: lixisenatide (ESNM26)

    This evidence summary has been updated and replaced by NICE guideline NG28.

    Evidence summary
    Published
    24 September 2013

  32. Secondary prevention in acute coronary syndrome: rivaroxaban (ESNM27)

    This evidence summary has been replaced by NICE technology appraisal guidance 335

    Evidence summary
    Published
    29 October 2013

  33. Transobturator foramen procedures for stress urinary incontinence (IPG107)

    The National Institute for Health and Clinical Excellence (NICE) issued full guidance to the NHS in England, Wales, Scotland and Northern Ireland on transobturator foramen procedures for stress incontinence in January 2005. This guidance has been withdrawn as the use of this procedure is now covered in NICE guideline CG40. NICE has no plans to carry out further assessment of this procedure under the Interventional Procedures Programme.

    Interventional procedures guidance
    Published
    23 January 2005

  34. Stereotactic radiosurgery for trigeminal neuralgia using the gamma knife (IPG11)

    This guidance has been updated and replaced by NICE interventional procedure guidance 85.

    Interventional procedures guidance
    Published
    23 September 2003

  35. Endoluminal gastroplication for gastro-oesophageal reflux disease (IPG115)

    This guidance has been updated and replaced by NICE interventional procedure guidance 404.

    Interventional procedures guidance
    Published
    23 February 2005

  36. Minimally invasive two-incision surgery for total hip replacement (IPG112)

    This guidance has been updated and replaced by NICE interventional procedure guidance 363.

    Interventional procedures guidance
    Published
    23 February 2005

  37. Complete cytoreduction and heated intraperitoneal intraoperative chemotherapy (Sugarbaker technique) for peritoneal carcinomatosis (IPG116)

    This guidance has been updated and replaced by NICE interventional procedure guidance 331.

    Interventional procedures guidance
    Published
    23 March 2005

  38. Mini-incision surgery for total knee replacement (IPG117)

    This guidance has been updated and replaced by NICE interventional procedure guidance 345.

    Interventional procedures guidance
    Published
    23 March 2005

  39. Posterior infracoccygeal sacropexy for vaginal vault prolapse (IPG125)

    This guidance has been updated and replaced by NICE interventional procedure guidance 281.

    Interventional procedures guidance
    Published
    18 May 2005

  40. Pancreatic islet cell transplantation (IPG13)

    NICE's guidance on pancreatic islet cell transplantation has now been replaced. Please go to NICE interventional procedure guidance 257 to view the full guidance on allogeneic pancreatic islet cell transplantation for type 1 diabetes mellitus and to NICE interventional procedure guidance 274 to view the full guidance on autologous pancreatic islet cell transplantation for improved glycaemic control after pancreatectomy issued to the NHS in England, Wales, Scotland and Northern Ireland.

    Interventional procedures guidance
    Published
    17 February 2003

  41. Insertion of extraurethral (non-circumferential) retropubic adjustable compression devices for stress urinary incontinence in women (IPG133)

    This guidance has been updated and replaced by NICE interventional procedures guidance 576.

    Interventional procedures guidance
    Published
    27 July 2005

  42. Prosthetic intervertebral disc replacement in the cervical spine (IPG143)

    This guidance has been updated and replaced by NICE interventional procedure guidance 341.

    Interventional procedures guidance
    Published
    23 November 2005

  43. Extracorporeal shock wave therapy for refractory tendinopathies (plantar fasciitis and tennis elbow) (IPG139)

    This guidance has been updated and replaced by NICE interventional procedure guidance 313.

    Interventional procedures guidance
    Published
    23 November 2005

  44. Transurethral radiofrequency needle ablation of the prostate (IPG15)

    This guidance has been updated and replaced by NICE guideline CG97.

    Interventional procedures guidance
    Published
    17 October 2003

  45. Laparoscopic radical prostatectomy (IPG16)

    This guidance has been updated and replaced by NICE interventional procedure guidance 193.

    Interventional procedures guidance
    Published
    23 October 2003

  46. Insertion of biological slings for stress urinary incontinence in women (IPG154)

    This guideline has been updated and replaced by NICE guideline NG123.

    Interventional procedures guidance
    Published
    25 January 2006

  47. Interspinous distraction procedures for spinal stenosis causing neurogenic claudication in the lumbar spine (IPG165)

    This guidance has been updated and replaced by NICE interventional procedure guidance 365.

    Interventional procedures guidance
    Published
    23 March 2006

  48. Mosaicplasty for knee cartilage defects (IPG162)

    This guidance has been updated and replaced by NICE interventional procedures guidance 607.

    Interventional procedures guidance
    Published
    22 March 2006

  49. Stapled transanal rectal resection for obstructed defaecation syndrome (IPG169)

    This guidance has been updated and replaced by NICE interventional procedure guidance 351.

    Interventional procedures guidance
    Published
    1 April 2006

  50. Endovascular closure of perimembranous ventricular septal defect (IPG172)

    This guidance has been updated and replaced by NICE interventional procedure guidance 336.

    Interventional procedures guidance
    Published
    23 May 2006